Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Nicolaas Schaap"'
Autor:
Marina Díaz-Beyá, Harry C. Schouten, Mauricette Michallet, Mohamad Mohty, Jordi Esteve, Jorge Sierra, Arnon Nagler, Gérard Socié, Myriam Labopin, Mahmoud Alijurf, Jakob Passweg, Nicolaas Schaap, Rainer Schwerdtfeger, Beelen Dietrich, Emmanuelle Polge, Johan Maertens, Liisa Volin
Publikováno v:
British Journal of Haematology, 189(5), 920-925. Wiley
British Journal of Haematology, 189, 5, pp. 920-925
British Journal of Haematology, 189, 920-925
British Journal of Haematology, 189, 5, pp. 920-925
British Journal of Haematology, 189, 920-925
Contains fulltext : 220562.pdf (Publisher’s version ) (Closed access) Acute myeloid leukaemia (AML) with t(6;9)(p23;q34) is a poor-risk entity, commonly associated with FLT3-ITD (internal tandem duplication). Allogeneic stem-cell tranplantation (al
Autor:
Mutlu Arat, Jenny Byrne, Ibrahim Yakoub-Agha, Sascha Dietrich, Johanna Tischer, Federica Sorà, Nicolaas Schaap, Eleni Tholouli, Francis Ayuk, Joan Hendrik Veelken, Yves Chalandon, Yener Koc, Henric Jan Blok, Johan Maertens, Per Ljungman, Maija Itälä-Remes, Jürgen Finke, Pavel Jindra, Jiri Mayer, Michael Stadler, Gérard Socié, Vanderson Rocha, Jakob Passweg, Arnon Nagler, Nicolaus Kröger, Aleksandar Radujkovic
Publikováno v:
Biology of Blood and Marrow Transplantation, 25, 10, pp. 2008-2016
Biology of Blood and Marrow Transplantation, Vol. 25, No 10 (2019) pp. 2008-2016
Biology of Blood and Marrow Transplantation
Biology of Blood and Marrow Transplantation, 25, 2008-2016
Biology of Blood and Marrow Transplantation, 25(10), 2008-2016. ELSEVIER SCIENCE INC
Biology of Blood and Marrow Transplantation, Vol. 25, No 10 (2019) pp. 2008-2016
Biology of Blood and Marrow Transplantation
Biology of Blood and Marrow Transplantation, 25, 2008-2016
Biology of Blood and Marrow Transplantation, 25(10), 2008-2016. ELSEVIER SCIENCE INC
The prognosis of patients with blast crisis (BC) chronic myeloid leukemia (CML) is still dismal. Allogeneic stem cell transplantation represents the only curative treatment option, but data on transplant outcomes are scarce. We therefore conducted a
Autor:
Upasana Sunil Arvindam, Daniel A. Vallera, Harry Dolstra, Dawn K. Schirm, Nicolaas Schaap, Paulien M.M. van Hauten, Jeffrey S. Miller, Bruce R. Blazar, Willemijn Hobo, Martin Felices
Publikováno v:
Leukemia, 35, 1586-1596
Leukemia
Leukemia, 35, 6, pp. 1586-1596
Leukemia
Leukemia, 35, 6, pp. 1586-1596
Contains fulltext : 234970.pdf (Publisher’s version ) (Closed access) The low 5-year survival rate for patients with acute myeloid leukemia (AML), primarily caused due to disease relapse, emphasizes the need for better therapeutic strategies. Disea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7adbf9f3b212d3c23c11cc36499c884
http://hdl.handle.net/2066/234970
http://hdl.handle.net/2066/234970
Autor:
Nicolaas Schaap, Willemijn Hobo, Harry Dolstra, Anniek B. van der Waart, Aafke de Ligt, Sjoerd Baardman, Joop H. Jansen, Charlotte M. Mousset
Publikováno v:
Cancer Immunology Immunotherapy, 69, 2259-2273
Cancer Immunology Immunotherapy, 69, 11, pp. 2259-2273
Cancer Immunology, Immunotherapy
Cancer Immunology Immunotherapy, 69, 11, pp. 2259-2273
Cancer Immunology, Immunotherapy
AKT-inhibition is a promising approach to improve T cell therapies; however, its effect on CD4+ T cells is insufficiently explored. Previously, we and others showed that AKT-inhibition during ex vivo CD8+ T cell expansion facilitates the generation o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::793f601d233b0ab0111583bd9985e780
http://hdl.handle.net/2066/229379
http://hdl.handle.net/2066/229379
Autor:
Ibrahim Yakoub-Agha, Xavier Poiré, Marek Trneny, Wilfried Schroyens, Linda Koster, Juan Bargay Lleonart, Denis Caillot, Péter Reményi, Nicolaas Schaap, Loic Fouillard, Anastasia Pouli, Maija Itälä-Remes, Dominique Bron, Nico Gagelmann, Vincenzo Pavone, Didier Blaise, Jean-Yves Cahn, Johan Maertens, Nicolaus Kröger, Rocio Parody Porras, Pietro Pioltelli, Roland Fenk, Jakob Passweg, Diderik Jan Eikema, Maurizio Musso, Stefan Schönland, Laurent Garderet
Publikováno v:
Biology of blood and marrow transplantation
Biology of Blood and Marrow Transplantation, 25, 11, pp. 2134-2142
Biology of Blood and Marrow Transplantation, 25, 2134-2142
Biology of blood and marrow transplantation, Vol. 25, no.11, p. 2134-2142 (2019)
Biology of Blood and Marrow Transplantation, 25, 11, pp. 2134-2142
Biology of Blood and Marrow Transplantation, 25, 2134-2142
Biology of blood and marrow transplantation, Vol. 25, no.11, p. 2134-2142 (2019)
Although high-dose therapy and autologous stem cell transplant combined with novel agents continues to be the hallmark of first-line treatment in newly diagnosed transplant-eligible multiple myeloma patients, the impact of tandem autologous or autolo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c756da7aef0ec31fe79a73fa5e8e3b2c
https://lirias.kuleuven.be/handle/123456789/639716
https://lirias.kuleuven.be/handle/123456789/639716
Autor:
Tim J. A. Hutten, J.H. Frederik Falkenburg, Willemijn Hobo, Michel G.D. Kester, Nicolaas Schaap, Rob Woestenenk, Sofia Berglund, Leo Luznik, Joop H. Jansen, Frans Maas, Wieger J. Norde, Ruo Chen Wang, Harry Dolstra
Publikováno v:
Biology of Blood and Marrow Transplantation, 24, 666-677
Biology of Blood and Marrow Transplantation, 24(4), 666-677
Biology of Blood and Marrow Transplantation
Biology of Blood and Marrow Transplantation, 24, 4, pp. 666-677
Biology of Blood and Marrow Transplantation, 24(4), 666-677
Biology of Blood and Marrow Transplantation
Biology of Blood and Marrow Transplantation, 24, 4, pp. 666-677
Allogeneic stem cell transplantation (allo-SCT) can be a curative treatment for patients with a hematologic malignancy due to alloreactive T cell responses recognizing minor histocompatibility antigens (MiHA). Yet tumor immune escape mechanisms can c
Autor:
Joop H. Jansen, Rob Woestenenk, Lex B. H. Bakker, Tim J. A. Hutten, Willemijn Hobo, Ben Joosten, Nicolaas Schaap, Hanny Fredrix, Harry Dolstra, Alessandra Cambi, Jurjen Tel, Soley Thordardottir, Gerben M. Franssen, Lisanne M. A. Janssen, Otto C. Boerman, Mirjam H.M. Heemskerk
Publikováno v:
Journal of Immunology, 197, 7, pp. 2715-25
Journal of Immunology, 197, 2715-25
Journal of Immunology, 197(7), 2715-2725
Journal of Immunology, 197, 2715-25
Journal of Immunology, 197(7), 2715-2725
Contains fulltext : 172057.pdf (Publisher’s version ) (Closed access) Potent immunotherapies are urgently needed to boost antitumor immunity and control disease in cancer patients. As dendritic cells (DCs) are the most powerful APCs, they are an at
Autor:
Nicolaas Schaap
Publikováno v:
HemaSphere. 3
Autor:
Sabine Gerull, Giorgia Battipaglia, Arnon Nagler, Johan Maertens, Patrice Chevallier, William Arcese, Jan J. Cornelissen, Mohamad Mohty, Azedine Djabali, Didier Blaise, Ali Bazarbachi, Joerg Halter, Jean El-Cheikh, Gérard Socié, Nicolaas Schaap, Edouard Forcade, Myriam Labopin, Jordi Esteve
Publikováno v:
Clinical Hematology International, Vol 1, Iss 1 (2019)
Acute myeloid leukemia (AML) with FLT3-mutation carries a poor prognosis, and allogeneic stem cell transplantation (allo-SCT) is recommended at first complete remission (CR1). We assessed 462 adults (median age 50 years) with FLT3-mutated AML allogra
Publikováno v:
British Journal of Haematology, 181, 38-53
British Journal of Haematology, 181, 1, pp. 38-53
British Journal of Haematology, 181, 1, pp. 38-53
Contains fulltext : 190712.pdf (Publisher’s version ) (Closed access) New immunotherapeutic interventions have revolutionized cancer treatment. The immune responsiveness of acute myeloid leukaemia (AML) was first demonstrated by allogeneic stem cel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6328fa2fa193855f4df9d556b222074
https://doi.org/10.1111/bjh.15078
https://doi.org/10.1111/bjh.15078